Improving influenza vaccination rates among adults

Kristin L. Nichol, MD, MPH, MBA
Professor of Medicine, University of Minnesota; Chief of Medicine and Director, Primary and Subspecialty Medicine Service Line, Minneapolis VA Medical Center

Address: Kristin L. Nichol, MD, Medicine Service (111), VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417; e-mail nicho014@umn.edu

The author has indicated that she has received consulting fees or honoraria for serving on advisory committees or review panels for the GlaxoSmithKline, MedImmune, and Novartis corporations, makers of influenza vaccines.

Kristin L. Nichol, MD, MPH, MBA
Professor of Medicine, University of Minnesota; Chief of Medicine and Director, Primary and Subspecialty Medicine Service Line, Minneapolis VA Medical Center

Address: Kristin L. Nichol, MD, Medicine Service (111), VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417; e-mail nicho014@umn.edu

The author has indicated that she has received consulting fees or honoraria for serving on advisory committees or review panels for the GlaxoSmithKline, MedImmune, and Novartis corporations, makers of influenza vaccines.

Kristin L. Nichol, MD, MPH, MBA
Professor of Medicine, University of Minnesota; Chief of Medicine and Director, Primary and Subspecialty Medicine Service Line, Minneapolis VA Medical Center

Address: Kristin L. Nichol, MD, Medicine Service (111), VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417; e-mail nicho014@umn.edu

The author has indicated that she has received consulting fees or honoraria for serving on advisory committees or review panels for the GlaxoSmithKline, MedImmune, and Novartis corporations, makers of influenza vaccines.